Bone
metastasis is a complication occurring in up to 70% of advanced
breast cancer patients. The
estrogen receptor-related receptor alpha (ERRα) has been implicated in
breast cancer and bone development, prompting us to examine whether ERRα may function in promoting the osteolytic growth of
breast cancer cells in bone. In a mouse xenograft model of metastatic human
breast cancer, overexpression of wild-type ERRα reduced
metastasis, whereas overexpression of a dominant negative mutant promoted
metastasis. Osteoclasts were directly affected and ERRα upregulated the osteoclastogenesis inhibitor,
osteoprotegerin (OPG), providing a direct mechanistic basis for understanding how ERRα reduced
breast cancer cell growth in bone. In contrast, ERRα overexpression increased
breast cancer cell growth in the mammary gland. ERRα-overexpressing primary
tumors were highly vascularized, consistent with an observed upregulation of angiogenic
growth factor, the
VEGF. In support of these findings, we documented that elevated expression of ERRα
mRNA in
breast carcinomas was associated with high expression of OPG and
VEGF and with
disease progression. In conclusion, our results show that ERRα plays a dual role in
breast cancer progression in promoting the local growth of
tumor cells, but decreasing metastatic growth of osteolytic lesions in bone.